References
- Dayton PA, Pearson D, Clark J, Simon S, Schumann PA, Zutshi R, Matsunaga TO, Ferrara KW. (2004). Ultrasonic analysis of peptide- and antibody-targeted microbubble contrast agents for molecular imaging of alphavbeta3-expressing cells. Mol Imaging, 3, 125–134.
- de Jong N, Bouakaz A, Frinking P. (2002). Basic acoustic properties of microbubbles. Echocardiography, 19, 229–240.
- Gao Z, Kennedy AM, Christensen DA, Rapoport NY. (2008). Drug-loaded nano/microbubbles for combining ultrasonography and targeted chemotherapy. Ultrasonics, 48(4), 260–270.
- Klibanov AL. (1999). Targeted delivery of gas-filled microspheres, contrast agents for ultrasound imaging. Adv Drug Deliv Rev, 37, 139–157.
- Koh PTL, Schwartz MP. (2003). CFD modelling of bubble-particle collision rates and efficiencies in a mineral flotation cell. Miner Eng, 16, 1055–1069.
- Lindner JR. (2004). Molecular imaging with contrast ultrasound and targeted microbubbles. J Nucl Cardiol, 11, 215–221.
- Lindner JR, Dayton PA, Coggins MP, Ley K, Song J, Ferrara K, Kaul S. (2000). Noninvasive imaging of inflammation by ultrasound detection of phagocytosed microbubbles. Circulation, 102, 531–538.
- McDannold NJ, Vykhodtseva NI, Hynynen K. (2006). Microbubble contrast agent with focused ultrasound to create brain lesions at low power levels: MR imaging and histologic study in rabbits. Radiology, 241, 95–106.
- Moreno JG, O’Hara SM, Gross S, Doyle G, Fritsche H, Gomella LG, Terstappen LW. (2001). Changes in circulating carcinoma cells in patients with metastatic prostate cancer correlate with disease status. Urology, 58, 386–392.
- Ophir J, Parker KJ. (1989). Contrast agents in diagnostic ultrasound. Ultrasound Med Biol, 15, 319–333.
- Pantel K, Brakenhoff RH. (2004). Dissecting the metastatic cascade. Nat Rev Cancer, 4, 448–456.
- Schutt EG, Klein DH, Mattrey RM, Riess JG. (2003). Injectable microbubbles as contrast agents for diagnostic ultrasound imaging: the key role of perfluorochemicals. Angew Chem Int Ed Engl, 42, 3218–3235.
- Singletary SE, Larry L, Tucker SL, Spitzer G. (1991). Detection of micrometastatic tumor cells in bone marrow of breast carcinoma patients. J Surg Oncol, 47, 32–36.
- Smith MR. (2003). Rituximab (monoclonal anti-CD20 antibody): mechanisms of action and resistance. Oncogene, 22, 7359–7368.
- Sun Y, Zhao S, Dayton PA, Ferrara KW. (2006). Observation of contrast agent response to chirp insonation with a simultaneous optical-acoustical system. IEEE Trans Ultrason Ferroelectr Freq Control, 53, 1130–1137.
- Von Bibra H, Voigt JU, Froman M, Bone D, Wranne B, Juhlin-Dannfeldt A. (1999). Interaction of microbubbles with ultrasound. Echocardiography, 16, 733–741.
- Wierda WG, Cantwell MJ, Woods SJ, Rassenti LZ, Prussak CE, Kipps TJ. (2000). CD40-ligand (CD154) gene therapy for chronic lymphocytic leukemia. Blood, 96, 2917–2924.
- Willmann JK, Paulmurugan R, Chen K, Gheysens O, Rodriguez-Porcel M, Lutz AM, Chen IY, Chen X, and Gambhir SS. (2008). US imaging of tumor angiogenesis with microbubbles targeted to vascular endothelial growth factor receptor type 2 in mice. Radiology, 246, 339–340.
- Zhao YZ, Lu CT. (2007). Recent advances in the applications of ultrasonic microbubbles as gene delivery systems. [Article in Chinese]. Yao Xue Xue Bao, 42, 127–131.